XAIR vs. MODD, CTCX, DXR, GBS, CTSO, LNSR, CODX, AKLI, LUCD, and RVP
Should you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Modular Medical (MODD), Carmell (CTCX), Daxor (DXR), GBS (GBS), Cytosorbents (CTSO), LENSAR (LNSR), Co-Diagnostics (CODX), Akili (AKLI), Lucid Diagnostics (LUCD), and Retractable Technologies (RVP). These companies are all part of the "surgical & medical instruments" industry.
Beyond Air (NASDAQ:XAIR) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment.
Beyond Air currently has a consensus target price of $10.75, suggesting a potential upside of 714.46%. Modular Medical has a consensus target price of $4.25, suggesting a potential upside of 147.09%. Given Beyond Air's higher possible upside, equities analysts plainly believe Beyond Air is more favorable than Modular Medical.
31.5% of Beyond Air shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 19.0% of Beyond Air shares are held by insiders. Comparatively, 32.3% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Beyond Air has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.
In the previous week, Modular Medical had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for Modular Medical and 0 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.96 beat Modular Medical's score of 0.88 indicating that Beyond Air is being referred to more favorably in the media.
Beyond Air's return on equity of -199.90% beat Modular Medical's return on equity.
Modular Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Beyond Air received 42 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 68.75% of users gave Beyond Air an outperform vote.
Summary
Beyond Air beats Modular Medical on 8 of the 14 factors compared between the two stocks.
Get Beyond Air News Delivered to You Automatically
Sign up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beyond Air Competitors List
Related Companies and Tools
